The axial spondyloarthritis (axSpA) treatment market is estimated to be valued at USD 6.02 billion in 2024 and is expected to reach USD 10 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031. https://www.zupyak.com/p/4477940/t/axial-spondyloarthritis-axspa-treatment-market-is-to-witness-high-growth-due-to-increasing-disease-prevalence-worldwide